Viral target and metabolism‐based rationale for combined use of recently authorized small molecule COVID‐19 medicines: Molnupiravir, nirmatrelvir, and remdesivir

D Yan, B Yan - Fundamental & Clinical Pharmacology, 2023 - Wiley Online Library
The COVID‐19 pandemic remains a major health concern worldwide, and SARS‐CoV‐2 is
continuously evolving. There is an urgent need to identify new antiviral drugs and develop …
被引用次数：7 相关文章

Viral target-and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: molnupiravir, nirmatrelvir and remdesivir.

D Yan, B Yan - Fundamental & Clinical Pharmacology, 2023 - europepmc.org
The COVID-19 pandemic remains a major health concern worldwide, and SARS-CoV-2 is
continuously evolving. There is an urgent need to identify new antiviral drugs and develop …

Viral target and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: Molnupiravir, nirmatrelvir, and remdesivir

D Yan, B Yan - Fundamental & clinical pharmacology, 2023 - pubmed.ncbi.nlm.nih.gov
The COVID-19 pandemic remains a major health concern worldwide, and SARS-CoV-2 is
continuously evolving. There is an urgent need to identify new antiviral drugs and develop …